All Shared Cases

Author: ahaines8
Date:
Test Case PA

<p>Our study recruits participants who qualify for CAP/RPV based on pre-screening evidence. The goal of the study is to optimize drug regimens for adolescents and young adults, and to gauge interest in and knowledge of LAIs among this… Read full case

Author: maunank
Date:
test case

<p>test</p>

Author: PreethiMol
Date:
Second line Treatment Options in Resource Limited

RVD - diagnosed in 2017

- failed first line

- - multiple defaults while on TenvirEM, EFV

- VL not suppressed after restarting same regime since April 2019

- HIV drug resistance test 23… Read full case

Author: DR MATIN AHMAD KHAN
Date:
Treatment -experienced with virologic failure

Here the patient is on DRV/r twice plus FTC/TDF and have wide spread mutations against RT, Protease Integrase and even Entry inhibitor gp41. 

What best would be to be included for this patient ?

1. IBA & DTG

2.FOS… Read full case

Author: DR MATIN AHMAD KHAN
Date:
Can we give ABC if HLA57 report pending ?

A 40 year comes for followp with virologically suppressed with RPV/TAF/FTC . he is started now  pantaprazole  for reflux oesophagitis and also being given Budesonide /Formetrol  for asthma .

His HLA B5701 is pending … Read full case

Author: sholzma1
Date:
NRTI sparing regimen in someone failing Biktarvy

I have a 43 year old man with CKD (stage IV, prior Cr ~3), treated HCV and HIV (on Biktarvy) who presented after a year w/o follow-up and found to have progressive renal failure, Cr 11. Admitted for initiation of HD. Reports compliance with… Read full case

Author: Ncwhelan3
Date:
ARV regimen change for 27 y.o. with congenital HIV

27 year old female not taking ART's for the last 5 months. The last ART Genvoya caused excessive nausea. She was well controlled on Bictegravir prior however developed apraxia of speech and right-sided muscle weakness. Although neurological… Read full case

Author: maunank
Date:
HIV/TB, INSTI resistance

40 year old patient with HIV, treatment experienced (prior history of TDF/FTC+RAL, TDF/FTC+RAL+ATVc), off ART for > 1 year, current genotype without resistance (but history of M184V and T97A), newly diagnosed with pulmonary TB.  Started… Read full case

Author: maunank
Date:
HIV/TB, INSTI resistance

40 year old patient with HIV, treatment experienced (prior history of TDF/FTC+RAL, TDF/FTC+RAL+ATVc), off ART for > 1 year, current genotype without resistance (but history of M184V and T97A), newly diagnosed with pulmonary TB.  Started… Read full case

Author: MatthewHamill
Date:
HBV/HCV/HIV M184V. Dolutegravir allergy

59yr old AA man. HIV since at least 2004. 

- On Dar/c and Descovy consistently for 13 months.

New onset of renal dysfunction - creat 2.1; eGFR 39 (Jan 2021). 

Previous creats 1.1 - 1.4; eGFR >63. May 2020… Read full case